Gilead Sciences' cell therapy Kite Pharma has bulked up its position in ... said the deal will "potentially accelerate Shoreline's timeline to the clinic, expand our pipeline opportunities and ...

Whatever you do, don’t call it a festival. There’s no set schedule or events during the two-day gathering, warns Dave Shenkman, owner of Kite Connection on the Huntington Beach Pier and ...

The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an ...

Google Maps saves your past travel data to a personal Timeline. The Timeline has been undergoing some recent changes, as Google transitions to on-device storage. Within the past day, a growing ...

Lucas Hunter loves to kite surf, so along with his sister Sophie he planned a trip to Colombia to take advantage of the “good waves” in the north of the country in late December last year.

Mankind Pharma, India’s fourth largest drugmaker ... although the Danish company has not clarified a timeline. Innovator Eli Lilly, whose weight loss drug Tirzepatide is sold under brand name ...

Hyliion Holdings’ KARNO generator delays raise concerns about its timeline. See why HYLN stock is a hold, with liquidity but ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist ...

Then came the threats of tariffs that the Indian pharma sector could face in the United States. How turbulent could the after-effects be of the possible tariffs? “The key strength of Indian ...

Kennedy Jr. — who also happens to now run the Department of Health and Human Services — have castigated the pharma sector for its all-too-cozy relationship with the FDA, including its penchant ...

Feb 19 (Reuters) - U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official confirmed to Reuters on Wednesday, as the industry tries to ...

curb hospital drug markups and clamp down on pharma middlemen. Regarding innovation, PhRMA says it will encourage the government to protect intellectual property at home and abroad, modernize the ...